Dolhnikoff Marisa, da Silva Luiz F F, de Araujo Bianca B, Gomes Higor A P, Fernezlian Sandra, Mulder Adri, Lindeman Jan H, Mauad Thais
Department of Pathology, School of Medicine, University of São Paulo, São Paulo, Brazil.
J Allergy Clin Immunol. 2009 May;123(5):1090-7, 1097.e1. doi: 10.1016/j.jaci.2009.02.032. Epub 2009 Apr 10.
Structural and inflammatory changes in asthma involve both the large and small airways, with involvement of the distal lung being related to disease severity. We have previously shown that changes in the extracellular matrix (ECM) composition of the distal lung are associated with loss of alveolar attachments in patients with fatal asthma. However, major ECM elements, such as collagen I and fibronectin and their regulators, have not been addressed at the distal level.
We sought to evaluate ECM remodeling in the distal lungs of asthmatic patients.
Using immunohistochemistry and image analysis, we determined the content of collagen I and III, fibronectin, and matrix metalloproteinases (MMPs) 1, 2, and 9 and tissue inhibitors of metalloproteinase (TIMPs) 1 and 2 in the large and small airways and lung parenchyma of 24 patients with fatal asthma and compared the results with those of 11 nonasthmatic control subjects. Protein content was defined as the area of positive staining divided by basement membrane or septum length.
We observed increased collagen I and decreased collagen III content in the small airways of asthmatic patients compared with that seen in control subjects. Greater fibronectin and MMP-1, MMP-2, and MMP-9 content was observed at the outer area of the small airways in asthmatic patients. MMP content was also increased in the peribronchiolar parenchyma in asthmatic patients. In contrast, TIMP expression was only increased in the large airways of asthmatic patients compared with that seen in control subjects.
The outer area of the small airways is a major site of ECM remodeling in fatal asthma, potentially contributing to functional changes and the loss of airway-parenchyma interdependence observed in patients with fatal asthma.
哮喘的结构和炎症变化涉及大、小气道,远端肺组织的受累与疾病严重程度相关。我们之前已经表明,致命性哮喘患者远端肺组织细胞外基质(ECM)组成的变化与肺泡附着丧失有关。然而,主要的ECM成分,如I型胶原和纤连蛋白及其调节因子,在远端水平尚未得到研究。
我们试图评估哮喘患者远端肺组织中的ECM重塑情况。
我们采用免疫组织化学和图像分析方法,测定了24例致命性哮喘患者大、小气道及肺实质中I型和III型胶原、纤连蛋白、基质金属蛋白酶(MMPs)1、2和9以及金属蛋白酶组织抑制剂(TIMPs)1和2的含量,并将结果与11例非哮喘对照受试者的结果进行比较。蛋白质含量定义为阳性染色面积除以基底膜或间隔长度。
与对照受试者相比,我们观察到哮喘患者小气道中I型胶原增加而III型胶原含量减少。在哮喘患者小气道的外周区域观察到纤连蛋白以及MMP-1、MMP-2和MMP-9的含量更高。哮喘患者支气管周围实质中的MMP含量也增加。相比之下,与对照受试者相比,TIMP表达仅在哮喘患者的大气道中增加。
小气道外周区域是致命性哮喘中ECM重塑的主要部位,可能导致功能变化以及在致命性哮喘患者中观察到的气道-实质相互依存关系丧失。